10x Insights
Loading account…
Companies / Healthcare / KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

HealthcareSurgical & Medical Instruments
Ticker KMTSKIRKLAND, WAFiscal year ends AprilBook value per share $3.80Diluted shares 58.6M

Kestra Medical Technologies, Inc. (NASDAQ: KMDX) is a medical device company focused on developing and commercializing innovative solutions for minimally invasive procedures. The company operates through its primary business segment of designing, manufacturing, and distributing specialized medical devices and related… From the company’s description.

Fiscal year 2026 · ends 04-30Changes are against fiscal 2025The amber dot is the latest twelve months, to 2026-07-31
Sales & profitability
$95.13M
+59.0% year over year
Last 12 mo $106.73M
-141.64%
+36.2 percentage points
Last 12 mo -134.48%
$-131.61M
−15.6% year over year
Last 12 mo $-149.87M
-50.69%
+4.7 percentage points
Last 12 mo -67.40%
Cash & financing
$-81.70M
−5.3% year over year
Last 12 mo $-87.72M
$-116.59M
−16.0% year over year
Last 12 mo $-122.79M
0.16
Was 0.20× a year earlier
Last 12 mo 0.33
54.2M
+120.4% year over year
Last 12 mo 58.6M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What KESTRA MEDICAL TECHNOLOGIES, LTD. does

In the company’s own words

Kestra Medical Technologies, Inc. (NASDAQ: KMDX) is a medical device company focused on developing and commercializing innovative solutions for minimally invasive procedures. The company operates through its primary business segment of designing, manufacturing, and distributing specialized medical devices and related products for healthcare providers and patients globally.

The company's core business centers on creating advanced medical technologies that enable physicians to perform complex procedures with reduced invasiveness, thereby improving patient outcomes and reducing recovery times. Kestra's product portfolio encompasses a range of devices and systems designed for various clinical applications, with particular emphasis on procedural efficiency and safety.

Kestra Medical Technologies operates as a subsidiary of Kestra Medical Technologies, Ltd., an exempted company incorporated in Bermuda, which serves as the parent entity. The company maintains operations across multiple geographic regions to serve its diverse customer base, which includes hospitals, surgical centers, and other healthcare facilities worldwide.

The company's business model relies on the development of proprietary technologies protected through intellectual property rights, regulatory approvals, and manufacturing capabilities. Kestra maintains regulatory compliance across multiple jurisdictions, including obtaining and maintaining necessary regulatory approvals and licensures required for the marketing and distribution of its medical devices.

The organization is supported by a dedicated workforce and maintains manufacturing and distribution infrastructure to support its commercial operations. The company's competitive positioning is built on its technological innovation, regulatory expertise, and ability to bring novel solutions to market while maintaining stringent quality and safety standards.

Kestra Medical Technologies' website is located at www.kestramedical.com. The company's financial structure includes secured term loan facilities arranged through BioPharma Credit PLC as collateral agent, with funding provided by specialized healthcare-focused investment vehicles, reflecting the capital-intensive nature of medical device development and commercialization.

Company details
Sector
Healthcare
Industry
Surgical & Medical Instruments
Headquarters
KIRKLAND, WA
Fiscal year end
April
CIK
1877184
SIC
3841

Financial performance, year by year

Fiscal 2025–2026 · USD
$-175.53M$-98.55M$-21.57M$55.41M$132.39M20252026Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns KESTRA MEDICAL TECHNOLOGIES, LTD. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

39
funds hold it
0 of 35
superinvestors hold it
$89.04M
held by funds, at market
6.1%
of shares held by funds

Largest fund holders · KESTRA MEDICAL TECHNOLOGIES, LTD.’s weight in each

Eventide Healthcare & Life Sciences Fund
ETAHX · MUTUAL FUND SERIES TRUST
1.95%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
SmallCap Growth Fund I
PPNMX · Principal Funds, Inc
0.35%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.01%of fund net assets
VANGUARD RUSSELL 2000 INDEX FUND
VTWO · VANGUARD SCOTTSDALE FUNDS
0.02%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do KESTRA MEDICAL TECHNOLOGIES, LTD. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of KESTRA MEDICAL TECHNOLOGIES, LTD.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in KESTRA MEDICAL TECHNOLOGIES, LTD.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.